Progressive multifocal leukoencephalopathy

FDA Clears IND Application and Grants Orphan Drug Designation to an Experimental Therapy for Progressive Multifocal Leukoencephalopathy
source: pixabay.com

FDA Clears IND Application and Grants Orphan Drug Designation to an Experimental Therapy for Progressive Multifocal Leukoencephalopathy

According to a story from PR Newswire, the cell therapy company Cellevolve Bio, Inc., recently announced that the US Food and Drug Administration (FDA) has advanced the development of its…

Continue Reading FDA Clears IND Application and Grants Orphan Drug Designation to an Experimental Therapy for Progressive Multifocal Leukoencephalopathy
FDA Clears IND Application For NT-I7, a PML Treatment
source: pixabay.com

FDA Clears IND Application For NT-I7, a PML Treatment

The FDA has recently accepted NeoImmuneTech's Investigational New Drug (IND) application for NT-17, a treatment for progressive multifocal leukoencephalopathy (PML). Now that the application has been cleared, the biopharmaceutical company…

Continue Reading FDA Clears IND Application For NT-I7, a PML Treatment
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Policy
Privacy Policy for CA Residents
EU Privacy Notice
Privacy Shield Policy

Facebook Twitter Tiktok Instagram Linkedin

© Copyright Patient Worthy